General Information |
| Board Constituency: |
Private sector |
| Organization Type - Primary: |
Private Sector |
| Organization Type - Secondary: |
Company |
| Is your organization legally registered in your country: |
Yes |
| Organization Reach: |
International |
| Organization Description: |
NanoLogix is a biotechnology company specializing in live cell, rapid diagnostics. Our kits are simple and reliable rapid test solutions that detect active threat bacteria and other microorganisms faster than traditional Petri culture technology. Our tests are more cost effective than molecular diagnostic technologies.
|
| |
| Total number of staff in your organization: |
11 - 25 |
| Number of full-time staff who are directly involved with TB: |
1 - 5 |
| Number of part-time staff who are directly involved with TB: |
1 - 5 |
| Number of volunteers who are directly involved with TB: |
0 |
| |
| What is your organization's annual budget (USD) dedicated to TB? |
Unable to disclose amount |
| How did you hear about the Stop TB Partnership: |
Other partners |
| Why do you wish join the Stop TB Partnership: |
Resource mobilization |
| |
| Are you a member of a Stop TB national partnership: |
No |
| Are you in contact with your national TB programme: |
No |
| Please tell us how your organization is contributing to your country's national TB control plan: |
| Development of affordable and rapid based technology for early detection of TB. |
| |
Geographical Reach |
| Which country is your headquarters located in: |
United States of America |
| Which WHO region is the main focus of your work: |
Global |
Which countries do you do operate in:
(This includes countries you are conducting activities in) |
United States of America
|
